Come up with a name for your new list and we'll add to it:
Cingulate Therapeutics raised a round of funding on July 11, 2018. Investors include
Werth Family Investment Associates.
Cingulate Therapeutics, LLC (CTx) is a privately held, clinical stage biopharmaceutical company focused on the development of innovative new products for the treatment of Attention Deficit/Hyperactivi…